This agreement between Alcon subsidiary of Novartis, and megabuscador Internet could revolutionize eye care, said the Swiss group through a statement.
This is because it will combine the technological advances of Google, miniaturization of electronics, with experience in the pharmaceutical field Novartis and medical devices.
"We look forward to working with Google to combine advanced technology and our extensive knowledge in biology, and to serve unmet medical needs," said Joseph Jimenez, CEO of Novartis, said in the press release.
Jimenez stressed that this agreement is an important step in understanding the disease beyond the limits of traditional medicine.


